New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis

作者：Heissig Beate^*; Ohki Koizumi Makiko; Tashiro Yoshihiko; Gritli Ismael; Sato Kusubata Kaori; Hattori Koichi

来源：International Journal of Hematology, 2012, 95(2): 131-137.

DOI：10.1007/s12185-012-1016-y

• Angiogenesis
• Myeloid cells
• Plasmin
• Protease
• Kit ligand
• MMP-9
• CD11b

Angiogenesis is a process by which new blood vessels form from preexisting vasculature. This process includes differentiation of angioblasts into endothelial cells with the help of secreted angiogenic factors released from cells such as bone marrow (BM)-derived cells. The fibrinolytic factor plasmin, which is a serine protease, has been shown to promote endothelial cell migration either directly, by degrading matrix proteins such as fibrin, or indirectly, by converting matrix-bound angiogenic growth factors into a soluble form. Plasmin can also activate other pericellular proteases such as matrix metalloproteinases (MMPs). Recent studies indicate that plasmin can additionally alter cellular adhesion and migration. We showed that factors of the fibrinolytic pathway can recruit BM-derived hematopoietic cells into ischemic/hypoxic tissues by altering the activation status of MMPs. These BM-derived cells can function as accessory cells that promote angiogenesis by releasing angiogenic signals. This review will discuss recent data regarding the role of the fibrinolytic system in controlling myeloid cell-driven angiogenesis. We propose that plasmin/plasminogen may be a potential target not only for development of effective angiogenic therapeutic strategies for the treatment of cancer, but also for development of strategies to promote ischemic tissue regeneration.

• 出版日期2012-2
• 单位河北医科大学